These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26305981)

  • 1. Cytokine treatment in cancer immunotherapy.
    Ardolino M; Hsu J; Raulet DH
    Oncotarget; 2015 Aug; 6(23):19346-7. PubMed ID: 26305981
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy.
    Malmberg KJ; Bryceson YT; Carlsten M; Andersson S; Björklund A; Björkström NK; Baumann BC; Fauriat C; Alici E; Dilber MS; Ljunggren HG
    Cancer Immunol Immunother; 2008 Oct; 57(10):1541-52. PubMed ID: 18317755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
    Lankester AC; Ball LM; Lang P; Handgretinger R
    Pediatr Clin North Am; 2010 Feb; 57(1):97-121. PubMed ID: 20307714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-class cancer therapeutic to stimulate natural killer cells.
    Sheridan C
    Nat Biotechnol; 2006 Jun; 24(6):597. PubMed ID: 16763573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potential role of NK cells in future anti-tumor immunotherapies].
    Iannello A; Débbeche O; Samarani S; Sabbagh S; Duval M; Ahmad A
    Med Sci (Paris); 2007 May; 23(5):502-8. PubMed ID: 17502066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for the use of NK cells in immunotherapy of human cancer.
    Ljunggren HG; Malmberg KJ
    Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells: In health and disease.
    Mandal A; Viswanathan C
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):47-55. PubMed ID: 25571788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the dual-functional capability of CIK cells be used to improve antitumor effects?
    Wang X; Yu W; Li H; Yu J; Zhang X; Ren X; Cao S
    Cell Immunol; 2014 Jan; 287(1):18-22. PubMed ID: 24355711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Functional Impact of NK Cells.
    Poli A; Michel T; Patil N; Zimmer J
    Trends Immunol; 2018 Jun; 39(6):460-472. PubMed ID: 29496432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
    Rosenberg SA; Lotze MT
    Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in immunotherapy for pediatric cancer].
    Xu X; Zhao H; Tang Y
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398
    [No Abstract]   [Full Text] [Related]  

  • 16. Delivery of DNA into natural killer cells for immunotherapy.
    Schoenberg K; Trompeter HI; Uhrberg M
    Methods Mol Biol; 2008; 423():165-72. PubMed ID: 18370197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cell-based cancer immunotherapy.
    Stagg J; Smyth MJ
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killers: cataloging immune cells for immunotherapy.
    Keener AB
    Nat Med; 2015 Mar; 21(3):207-8. PubMed ID: 25742450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.